Archives for June 2019

Introduction To Ufovax & It’s Technology & Products (In Chinese)

June 5, 2019

Publication entitled “Proof of concept forrational design of hepatitis C virus E2 core nanoparticle vaccines” in Science Advances.
News release by Scripps Research on the latest research paper on HCV vaccine co-sponsored by NIH and Ufovax
Ufovax successfully extended its Nanoparticle vaccine technology to SARS-CoV-2
U.S. Patent & Trademark Office has allowed Scripps Research patent application HIV-1 GP140 Immunogens Comprising Modified NHR1 Regions That Stabilize Pre-fusion Conformations.
Introduction To Ufovax & It’s Technology & Products (In Chinese)

3801 Kennett Pike
Ste. A101, #4482
Wilmington, DE
19807-9998
info@ufovax.com